Skip to content

Drug interactions

Daclatasvir + Mifepristone

Severity: Minor

Daclatasvir and Mifepristone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone, a CYP3A4 inhibitor, may increase daclatasvir concentrations. Daclatasvir has a wide therapeutic margin, so the effect is usually modest.

What this interaction means in plain words

Daclatasvir and Mifepristone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Daclatasvir belongs to Anti Virals; Mifepristone belongs to Endocrine.

Evidence level: Low

Why it happens

CYP3A4 inhibition by mifepristone reduces daclatasvir clearance.

What to do

No routine dose change; monitor for adverse effects such as headache, fatigue and bradycardia, especially if combined with amiodarone.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daclatasvir and Mifepristone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Daclatasvir with Mifepristone?

MediHelp rates the interaction as minor. Daclatasvir and Mifepristone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Mifepristone, a CYP3A4 inhibitor, may increase daclatasvir concentrations. Daclatasvir has a wide therapeutic margin, so the effect is usually modest.

How serious is the interaction between Daclatasvir and Mifepristone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change; monitor for adverse effects such as headache, fatigue and bradycardia, especially if combined with amiodarone.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in